PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma

  • Fiona Brown-Burke
  • , Inah Hwang
  • , Shelby Sloan
  • , Claire Hinterschied
  • , Jo Beth Helmig-Mason
  • , Mackenzie Long
  • , Wing Keung Chan
  • , Alexander Prouty
  • , Ji Hyun Chung
  • , Yang Zhang
  • , Satishkumar Singh
  • , Youssef Youssef
  • , Neha Bhagwat
  • , Zhengming Chen
  • , Selina Chen-Kiang
  • , Maurizio Di Liberto
  • , Olivier Elemento
  • , Lalit Sehgal
  • , Lapo Alinari
  • , Kris Vaddi
    • Peggy Scherle, Rosa Lapalombella, Jihye Paik, Robert A. Baiocchi

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry